The Use of Urine Mycobacterium tuberculosis Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non–muscle‑invasive Bladder Cancer

European Urology Open Science(2021)

引用 3|浏览3
暂无评分
摘要
In intermediate- or high-risk non–muscle-invasive bladder cancer patients after intravesical bacillus Calmette-Guérin (BCG) therapy, Mycobacterium tuberculosis complex polymerase chain reaction (MTC-PCR) positivity at least once was a significant prognostic factor in recurrence. A new adequate biomarker, urine MTC-PCR, is very useful noninvasive surrogate marker to predict the recurrence after BCG therapy.
更多
查看译文
关键词
Bladder cancer,Bacillus Calmette-Guérin,Non–muscle invasive,Mycobacterium tuberculosis complex polymerase chain reaction
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要